Join to view full profile
1802 Sixth Ave SBirmingham, AL 35233
Dr. Hamilton is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Hematology and Medical Oncology, 2000 - 2002- University of Alabama Hospital (Birmingham)Residency, Internal Medicine, 1995 - 1998
- University of Alabama HospitalInternship, Transitional Year, 1994 - 1995
University of Kentucky College of MedicineClass of 1994
Certifications & Licensure
AL State Medical License 1996 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Cancer Genetics Risk Assessment City of Hope, 2022-2023
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification Greenway Prime Suite, Greenway Health, LLC, 2012, 2014, 2017
Publications & Presentations
PubMed
- 3 citationsDARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis.Evan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, Geoffrey Gotto, Alberto Briganti
Prostate Cancer and Prostatic Diseases. 2026-09-01 - Darolutamide With Concomitant Lipid-Modifying Agents in Nonmetastatic Castration-Resistant Prostate Cancer.Murilo A Luz, Alberto Briganti, Declan G Murphy, Christopher M Pieczonka, Hiroyoshi Suzuki
JAMA Network Open. 2026-08-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
